VascularReport
Classifications · Venous disease

VCSS — Venous Clinical Severity Score

CEAP describes, VCSS measures. Created precisely to overcome the limitation of CEAP — a static classification that is insensitive to change — the VCSS scores ten clinical attributes from 0 to 3 and produces a number that can be compared before and after treatment.

Interactive tool

Calculate the VCSS

Assess one leg at a time, according to the 2010 revision. The maximum score is 30.

How to use it

Instructions

The ten attributes and grading criteria

Attribute0 — none1 — mild2 — moderate3 — severe
Pain or other discomfortNoneOccasional, not restricting activityDaily, interfering with but not preventing regular activitiesDaily, limiting most regular activities
Varicose veins (≥ 3 mm, standing)NoneFew, scattered; includes corona phlebectaticaConfined to calf or thighInvolving calf and thigh
Venous oedemaNoneLimited to foot and ankleAbove the ankle but below the kneeTo the knee and above
Skin pigmentationNone or focalLimited to the perimalleolar areaDiffuse over the lower third of the calfWider distribution, above the lower third
InflammationNoneLimited to the perimalleolar areaDiffuse over the lower thirdWider distribution, above the lower third
IndurationNoneLimited to the perimalleolar areaDiffuse over the lower thirdWider distribution, above the lower third
Active ulcers: number012≥ 3
Active ulcer: duration (longest)None< 3 months3 months – 1 yearNot healed for > 1 year
Active ulcer: size (largest)NoneDiameter < 2 cmDiameter 2 – 6 cmDiameter > 6 cm
Use of compression therapyNot usedIntermittent use of stockingsStockings worn most daysFull compliance with stockings

Scoring notes

  • Assess one leg at a time: a bilateral report should give two separate scores.
  • Pigmentation presumes a venous origin: do not count focal pigmentation over varicose veins, or pigmentation from other chronic diseases.
  • Inflammation means more than recent pigmentation: erythema, cellulitis, venous eczema, dermatitis. Induration includes chronic oedema with fibrosis, hypodermitis, atrophie blanche and lipodermatosclerosis.
  • Compression: the item measures adherence, not the indication. A high score means the patient wears stockings regularly, i.e. needs significant support to control the disease. In the 2010 revision, leg elevation is no longer part of the item, as it was in the original 2000 version.
  • The three ulcer items refer to active ulcers (duration of the longest, size of the largest); a healed ulcer does not count.
  • The 2010 revision made the definitions more operational than the original 2000 version, clearly improving inter-observer agreement.

Clinical references

Guidelines and interpretation

How to read the score

The VCSS has no formal diagnostic thresholds: it is a continuous measure of severity. The bands below are a practical reference widely used in the literature, not an official classification.

ScoreIndicative severity
0 – 4Mild disease
5 – 9Moderate disease
10 – 14Severe disease
≥ 15Very severe disease

The right use: comparison over time

The value of the VCSS lies in the difference between two assessments of the same patient. A reduction of 3–4 points after treatment is regarded as clinically significant. In registries and outcome studies the VCSS is the standard indicator for documenting the result of thermal or non-thermal saphenous ablation, sclerotherapy, phlebectomy, iliocaval venous stenting and structured compression therapy.

The SVS/AVF guidelines on varicose veins and venous ulcers recommend recording the VCSS at baseline and at follow-up in treated patients, together with the CEAP class and a quality-of-life questionnaire.

Relationship with the other tools

ToolWhat it doesSensitivity to change
CEAPDescribes and classifies clinical signs, etiology, anatomy and pathophysiologyLow: the C class rarely changes after treatment
VCSSGrades overall clinical severityHigh: it is the reference tool for measuring outcome
VillaltaDiagnoses and grades post-thrombotic syndromeModerate, specific to the post-thrombotic picture
CIVIQ-20, AVVQ, VEINES-QOLMeasure quality of life as perceived by the patientHigh, but on a different dimension from the clinical one
Why CEAP is not enough

A successfully treated C6 patient with a healed ulcer becomes C5: the C class records change only coarsely and never falls below the highest level reached. Two patients who are both C2 may have completely different disease in terms of extent, symptoms and functional impact. The VCSS was created precisely to make this difference visible.

Limitations

  • The compression item is debated: it measures adherence to treatment, not a sign of disease, and some authors exclude it from analyses.
  • The score gives the same weight to pain and oedema, which have very different impacts on quality of life.
  • It discriminates poorly in mild disease, where most patients cluster between 2 and 5 points.

References

Sources

  • Rutherford RB. et al., J Vasc Surg 2000 — Venous severity scoring: an adjunct to venous outcome assessment.
  • Vasquez MA. et al., J Vasc Surg 2010 — Revision of the venous clinical severity score: venous outcomes consensus statement (American Venous Forum).
  • Gloviczki P. et al., J Vasc Surg 2011; J Vasc Surg Venous Lymphat Disord 2023–2024 — SVS/AVF (and AVLS) clinical practice guidelines for varicose veins and chronic venous disease.
  • Passman MA. et al., J Vasc Surg 2011 — Validation of Venous Clinical Severity Score with other venous severity assessment tools.
Disclaimer

Quick-reference tool for healthcare professionals. It does not replace the original guidelines, the summaries of product characteristics or the specialist's clinical judgement. All calculations run in the browser: no patient data is transmitted to or stored on any server.